Elucidating the tumor-suppressive mechanisms of GLS2 in the context of liver cancer, Suzuki et al., demonstrated that GLS2 can inhibit HCC in vivo by promoting ferroptosis. Here, GLS2 is linked to hepatocellular carcinoma.